4.6 Article

Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infection

期刊

JOURNAL OF IMMUNOLOGY
卷 180, 期 5, 页码 2957-2966

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.5.2957

关键词

-

资金

  1. NHLBI NIH HHS [R01 HL033391-20, R01 HL033391-24, R01 HL071875-04, R01 HL033391, HL33391, R01 HL033391-27, R01 HL033391-23, R01 HL033391-19, R01 HL033391-18, R01 HL033391-21, R01 HL071875, R01 HL033391-22] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI015608, R01 AI037293-09, T32 AI007046, R01 AI037293-11, R01 AI037293-12, R01 AI037293-10, R01 AI015608-25, R01 AI015608-27, AI15608, AI37293, R01 AI015608-26, R37 AI015608, R01 AI037293-13, T32 AI007496, T32 AI07496, R01 AI037293-14, R01 AI037293, R01 AI015608-28, R01 AI015608-29] Funding Source: Medline

向作者/读者索取更多资源

The memory CD4(+) T cell response to the respiratory syncytial virus (RSV) attachment (G) protein in the lungs of primed BALB/c mice undergoing challenge pulmonary RSV infection is dominated by effector T cells expressing a single V beta-chain, V beta 14. We have used V beta 14 expression to examine the kinetics of the activation, accumulation, and acquisition of the effector activity of memory CD4(+) T cells responding to pulmonary infection. This analysis revealed that proliferative expansion and effector CD4(+) T cell differentiation preferentially occur in the respiratory tract following rapid activation within and egress from the lymph nodes draining the respiratory tract. These findings suggest that, in response to natural infection at a peripheral mucosal site such as the lungs, memory CD4(+) T cell expansion and differentiation into activated effector T cells may occur predominantly in the peripheral site of infection rather than exclusively in the lymph nodes draining the site or infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Cytokines and CD8 T cell immunity during respiratory syncytial virus infection

Megan E. Schmidt, Steven M. Varga

CYTOKINE (2020)

Article Immunology

Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice

Megan E. Schmidt, Antonius G. P. Oomens, Steven M. Varga

JOURNAL OF IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Airway Surface Liquid Has Innate Antiviral Activity That Is Reduced in Cystic Fibrosis

Abigail R. Berkebile, Jennifer A. Bartlett, Mahmoud Abou Alaiwa, Steven M. Varga, Ultan F. Power, Paul B. McCray

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)

Editorial Material Immunology

Editorial: Orchestration of an Immune Response to Respiratory Pathogens

Steven M. Varga, Andrea J. Sant

FRONTIERS IN IMMUNOLOGY (2019)

Article Immunology

Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection

Megan E. Schmidt, David K. Meyerholz, Steven M. Varga

MUCOSAL IMMUNOLOGY (2020)

Article Immunology

Current Insights in the Development of Efficacious Vaccines Against RSV

Jorge A. Soto, Laura M. Stephens, Kody A. Waldstein, Gisela Canedo-Marroquin, Steven M. Varga, Alexis M. Kalergis

FRONTIERS IN IMMUNOLOGY (2020)

Article Immunology

Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus

Laura M. Stephens, Kathleen A. Ross, Kody A. Waldstein, Kevin L. Legge, Jason S. McLellan, Balaji Narasimhan, Steven M. Varga

Summary: The novel RSV vaccine RSVNanoVax showed protective effects against RSV infection in experiments, reducing weight loss and pulmonary dysfunction, with protection lasting at least 6 months. Additionally, the vaccine was able to rapidly clear RSV from the lungs, induce tissue-resident memory T cells, and produce neutralizing antibodies against RSV.

JOURNAL OF IMMUNOLOGY (2021)

Article Biology

Protective function and durability of mouse lymph node-resident memory CD8+ T cells

Scott M. Anthony, Natalija Van Braeckel-Budimir, Steven J. Moioffer, Stephanie van de Wall, Qiang Shan, Rahul Vijay, Ramakrishna Sompallae, Stacey M. Hartwig, Isaac J. Jensen, Steven M. Varga, Noah S. Butler, Hai-Hui Xue, Vladimir P. Badovinac, John T. Harty

Summary: IAV infection generates Trm CD8(+)T cells in mice, while repeated antigen exposure produces 4M CD8(+)T cells with enhanced protective capacity. Enhanced protection by 4M cells is associated with increased expression of granzyme A/B and stable maintenance of CD69(+)CD103(+) 4M CD8(+)T cells, improving control of viral infections in mLN.
Review Immunology

Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population

Laura M. Stephens, Steven M. Varga

Summary: RSV is commonly associated with acute lower respiratory tract infections in infants and children, but also causes high disease burden in the elderly; RSV infection in aged individuals results in more severe disease symptoms, leading to higher hospitalizations and deaths in the elderly; Developing an RSV vaccine for elderly populations is challenging due to age-related defects in the immune system, but remains an important target for public health prevention strategies.

VACCINES (2021)

Article Immunology

Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection

Stacey M. Hartwig, Ann M. Miller, Steven M. Varga

Summary: Respiratory infections are a significant cause of illness and death, and the order in which viral infections are acquired plays a critical role in disease severity and the host immune response. In a study involving mice, it was found that being infected with respiratory syncytial virus (RSV) before influenza A virus (IAV) led to reduced weight loss and increased survival compared to being infected with IAV alone.

JOURNAL OF IMMUNOLOGY (2022)

Article Virology

Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model

Laura M. Stephens, Kathleen A. Ross, Jason S. McLellan, Balaji Narasimhan, Steven M. Varga

Summary: RSV infection causes significant infections and deaths in children and elderly adults each year. There is currently no licensed vaccine for RSV prevention. This study developed a vaccine candidate, RSVNanoVax, which provided long-term protection and immunity in outbred Swiss Webster mice.

JOURNAL OF VIROLOGY (2022)

Article Biochemical Research Methods

Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond

Kody A. Waldstein, Jirong Yi, Michael Myung Cho, Raghu Mudumbai, Xiaodong Wu, Steven M. Varga, Weiyu Xu

Summary: The rapid spread of SARS-CoV-2 has highlighted the need for innovative testing approaches for future pandemics. In this study, a novel sample pooling procedure based on compressed sensing theory is presented, which accurately identifies virally infected patients at high prevalence rates. The method reduces the number of tests required and provides quantification of individual sample viral load within a pool.

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Microbiology

Respiratory viruses and the inflammasome: The double-edged sword of inflammation

Kody A. Waldstein, Steven M. Varga

PLOS PATHOGENS (2022)

Review Virology

Nanoparticle vaccines against respiratory syncytial virus

Laura M. Stephens, Steven M. Varga

FUTURE VIROLOGY (2020)

暂无数据